No Data
No Data
Express News | NewAmsterdam Pharma Announces Appointments of Mark C. Mckenna and Wouter Joustra to Its Board of Directors
Is EnGene Holdings (NASDAQ:ENGN) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Morgan Stanley Maintains EnGene Holdings(ENGN.US) With Buy Rating, Maintains Target Price $40
Morgan Stanley analyst Jeffrey Hung maintains $enGene Holdings(ENGN.US)$ with a buy rating, and maintains the target price at $40.According to TipRanks data, the analyst has a success rate of 55.7% an
Express News | EnGene Holdings Inc : Leerink Partners Cuts Target Price to $27 From $31
Why Are EnGene Holdings Shares Trading Lower Friday?
EnGene Holdings Inc. (NASDAQ:ENGN) shares are trading lower Friday after the company, reported its financial results for the second quarter.What To Know: EnGene Holdings announced a net loss of $15.0
Express News | EnGene Holdings Shares Are Trading Lower After the Company Reported Q2 Financial Results
No Data